Biosurgery Market Size, Share, Industry Trends and Forecast to 2030

Biosurgery Market Size & CAGR in 2021

The biosurgery market is anticipated to reach a market size of USD 8.5 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 6.2% from 2021 to 2028. The increasing demand for minimally invasive surgeries and the growing prevalence of chronic diseases are driving the growth of the biosurgery market.

COVID-19 Impact on the Biosurgery Market

The COVID-19 pandemic had a significant impact on the biosurgery market. The lockdowns and restrictions imposed to curb the spread of the virus led to the postponement of elective surgeries, affecting the demand for biosurgery products. However, as healthcare systems adapt to the new normal, the biosurgery market is expected to bounce back and witness steady growth in the coming years.

Biosurgery Dynamics

The biosurgery market is driven by factors such as the increasing prevalence of chronic wounds, rising geriatric population, and advancements in surgical techniques. The market is also influenced by factors like the growing demand for minimally invasive procedures, technological advancements in biomaterials, and the rising adoption of biological products in surgical interventions.

Segments and Related Analysis

The biosurgery market is segmented based on product type, application, and end-user. Product types include surgical sealants, hemostatic agents, soft tissue management, and bone graft substitutes. Applications include orthopedic surgery, general surgery, cardiovascular surgery, and others. End-users comprise hospitals, ambulatory surgical centers, and specialty clinics.

By Region Analysis

The biosurgery market is analyzed across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market due to the presence of advanced healthcare infrastructure and increasing technological advancements. Europe follows closely, driven by the rising prevalence of chronic diseases and the growing aging population.

Key Market Players and Competitive Landscape

Key players in the biosurgery market include Johnson & Johnson, Baxter International Inc., BD, CryoLife Inc., Medtronic PLC, Stryker Corporation, Sanofi, B. Braun Melsungen AG, Integra Lifesciences Holdings Corporation, and Maquet Getinge Group. These companies focus on strategic partnerships, product launches, and mergers and acquisitions to enhance their market presence and expand their product portfolio.

Recent Happenings in the Biosurgery Market

- In 2022, Johnson & Johnson launched a new biosurgery product for soft tissue management, aimed at improving surgical outcomes. - Baxter International Inc. announced a partnership with a leading research institute to develop cutting-edge biosurgery solutions for cardiovascular surgeries. - Medtronic PLC introduced a novel hemostatic agent for use in orthopedic procedures, catering to the growing demand for innovative biosurgery products. - Stryker Corporation expanded its biosurgery portfolio with the acquisition of a specialized company focused on advanced wound care solutions. - Sanofi collaborated with a biotechnology startup to develop groundbreaking biomaterials for use in biosurgery, leveraging the latest innovations in the field.